Lista de obras - Magdalena Ratajska - Dominio Público Uruguay

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number

artículo científico publicado en 2016

Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example

artículo científico publicado en 2015

Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability.

scientific article published on 21 December 2016

BARD1 is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation

artículo científico publicado en 2019

Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects

scientific article published on 29 August 2019

Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms

artículo científico publicado en 2015

Cancer predisposing BARD1 mutations in breast-ovarian cancer families

scientific article published on 23 February 2011

Concurrent DNA Copy-Number Alterations and Mutations in Genes Related to Maintenance of Genome Stability in Uninvolved Mammary Glandular Tissue from Breast Cancer Patients

artículo científico publicado en 2015

Cornelia de Lange syndrome associated with a de-novo novel NIPBL splice-site mutation and a coincidental inherited translocation t(3;5)(p13;q11)

artículo científico publicado en 2011

Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer.

artículo científico publicado en 2017

Detection of somatic BRCA1/2 mutations in ovarian cancer - next-generation sequencing analysis of 100 cases

artículo científico publicado en 2016

Differential Expression of BARD1 Isoforms in Melanoma

High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland

scientific article published on 07 November 2007

Loss of heterozygosity at BRCA1/2 loci in hereditary and sporadic ovarian cancers

artículo científico publicado en 2009

Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing

artículo científico publicado en 2014

New concepts on BARD1: Regulator of BRCA pathways and beyond

artículo científico publicado en 2016

Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe

artículo científico publicado en 2015

Prevalence of the most frequent BRCA1 mutations in Polish population

artículo científico publicado en 2011

Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients

article

The 30 kb deletion in the APOBEC3 cluster decreases APOBEC3A and APOBEC3B expression and creates a transcriptionally active hybrid gene but does not associate with breast cancer in the European population

artículo científico publicado en 2017

The angiotensinogen AGT p.M235T gene polymorphism may be responsible for the development of severe anaphylactic reactions to insect venom allergens.

artículo científico publicado en 2010

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer

artículo científico publicado en 2021

Variant Identification in BARD1, PRDM9, RCC1, and RECQL in Patients with Ovarian Cancer by Targeted Next-generation Sequencing of DNA Pools

artículo científico publicado en 2022

Lista de obras de Magdalena Ratajska

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number

Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example

Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability.

BARD1 is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation

Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects

Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms

Cancer predisposing BARD1 mutations in breast-ovarian cancer families

Concurrent DNA Copy-Number Alterations and Mutations in Genes Related to Maintenance of Genome Stability in Uninvolved Mammary Glandular Tissue from Breast Cancer Patients

Cornelia de Lange syndrome associated with a de-novo novel NIPBL splice-site mutation and a coincidental inherited translocation t(3;5)(p13;q11)

Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer.

Detection of somatic BRCA1/2 mutations in ovarian cancer - next-generation sequencing analysis of 100 cases

Differential Expression of BARD1 Isoforms in Melanoma

High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland

Loss of heterozygosity at BRCA1/2 loci in hereditary and sporadic ovarian cancers

Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing

New concepts on BARD1: Regulator of BRCA pathways and beyond

Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe

Prevalence of the most frequent BRCA1 mutations in Polish population

Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients

The 30 kb deletion in the APOBEC3 cluster decreases APOBEC3A and APOBEC3B expression and creates a transcriptionally active hybrid gene but does not associate with breast cancer in the European population

The angiotensinogen AGT p.M235T gene polymorphism may be responsible for the development of severe anaphylactic reactions to insect venom allergens.

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer

Variant Identification in BARD1, PRDM9, RCC1, and RECQL in Patients with Ovarian Cancer by Targeted Next-generation Sequencing of DNA Pools